{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:47:17Z","timestamp":1785757637607,"version":"3.56.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011710","name":"Shaanxi Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["2025SF-YBXM-491"],"award-info":[{"award-number":["2025SF-YBXM-491"]}],"id":[{"id":"10.13039\/501100011710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018921","name":"Yulin Science and Technology Bureau","doi-asserted-by":"publisher","award":["2023-SF-59"],"award-info":[{"award-number":["2023-SF-59"]}],"id":[{"id":"10.13039\/100018921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018921","name":"Yulin Science and Technology Bureau","doi-asserted-by":"publisher","award":["YF-2021-72"],"award-info":[{"award-number":["YF-2021-72"]}],"id":[{"id":"10.13039\/100018921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jep.2026.121783","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T05:59:02Z","timestamp":1777701542000},"page":"121783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Qinggan Jiangzhi Cha ameliorates NAFLD by modulating the AGE-RAGE\/PRKCA\/MAPK3\/AP-1 signaling axis"],"prefix":"10.1016","volume":"368","author":[{"given":"Yu","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhili","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7929-3119","authenticated-orcid":false,"given":"Fanrong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jep.2026.121783_bib1","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.jep.2026.121783_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2023.109414","article-title":"Quercetin ameliorates nonalcoholic fatty liver disease (NAFLD) via the promotion of AMPK-mediated hepatic mitophagy","volume":"120","author":"Cao","year":"2023","journal-title":"J. Nutr. Biochem."},{"issue":"1","key":"10.1016\/j.jep.2026.121783_bib3","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jep.2026.121783_bib4","article-title":"Effects of Shugan-Jianpi recipe on the expression of the p38 MAPK\/NF-\u03baB signaling pathway in the hepatocytes of NAFLD rats","volume":"5","author":"Deng","year":"2018","journal-title":"Medicines (Basel)"},{"issue":"1","key":"10.1016\/j.jep.2026.121783_bib5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13020-024-00894-1","article-title":"Integrated traditional Chinese and Western medicine in the prevention and treatment of non-alcoholic fatty liver disease: future directions and strategies","volume":"19","author":"Ding","year":"2024","journal-title":"Chin. Med."},{"issue":"9","key":"10.1016\/j.jep.2026.121783_bib6","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.1039\/D4FO00586D","article-title":"Integration of network pharmacology, lipidomics, and transcriptomics analysis to reveal the mechanisms underlying the amelioration of AKT-induced nonalcoholic fatty liver disease by total flavonoids in Vine tea","volume":"15","author":"Du","year":"2024","journal-title":"Food Funct."},{"issue":"11","key":"10.1016\/j.jep.2026.121783_bib7","doi-asserted-by":"crossref","first-page":"15825","DOI":"10.1007\/s00210-025-04271-z","article-title":"Proanthocyanidin and mitoglitazone suppress lipogenesis by targeting ferroptosis in metabolic dysfunction-associated steatohepatitis","volume":"398","author":"El-Naby","year":"2025","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.jep.2026.121783_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijbiomac.2022.02.056","article-title":"Gardenia jasminoides ellis polysaccharide ameliorates cholestatic liver injury by alleviating gut microbiota dysbiosis and inhibiting the TLR4\/NF-\u03baB signaling pathway","volume":"205","author":"Fang","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"issue":"7","key":"10.1016\/j.jep.2026.121783_bib9","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.jep.2026.121783_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e23336","article-title":"Kaempferol and nicotiflorin ameliorated alcohol-induced liver injury in mice by miR-138-5p\/SIRT1\/FXR and gut microbiota","volume":"10","author":"Ge","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.jep.2026.121783_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154768","article-title":"Therapeutic application of natural products: NAD(+) metabolism as potential target","volume":"114","author":"Guo","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jep.2026.121783_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1050709","article-title":"\"Liver-gut\" axis: a target of traditional Chinese medicine for the treatment of non-alcoholic fatty liver disease","volume":"13","author":"Guo","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.jep.2026.121783_bib13","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.molimm.2025.11.006","article-title":"Complement factor D is a drug target for metabolic-associated fatty liver disease","volume":"188","author":"Guo","year":"2025","journal-title":"Mol. Immunol."},{"issue":"11","key":"10.1016\/j.jep.2026.121783_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18112466","article-title":"The role of Glyoxalase-I (Glo-I), advanced glycation endproducts (AGEs), and their receptor (RAGE) in chronic liver disease and hepatocellular carcinoma (HCC)","volume":"18","author":"Hollenbach","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.jep.2026.121783_bib15","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1039\/C6FO01585A","article-title":"The hepatoprotective effect of Phyllanthus emblica L. fruit on high fat diet-induced non-alcoholic fatty liver disease (NAFLD) in SD rats","volume":"8","author":"Huang","year":"2017","journal-title":"Food Funct."},{"issue":"4","key":"10.1016\/j.jep.2026.121783_bib16","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"9","key":"10.1016\/j.jep.2026.121783_bib17","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s41575-025-01089-1","article-title":"Gut microbiome in metabolic dysfunction-associated steatotic liver disease and associated hepatocellular carcinoma","volume":"22","author":"Lau","year":"2025","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.jep.2026.121783_bib18","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.54707","article-title":"Estimated burden of metabolic dysfunction-associated steatotic liver disease in US adults, 2020 to 2050","volume":"8","author":"Le","year":"2025","journal-title":"JAMA Netw. Open"},{"issue":"12","key":"10.1016\/j.jep.2026.121783_bib19","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1007\/s12011-024-04093-9","article-title":"Grape seed proanthocyanidins protect pancreatic \u03b2 cells against ferroptosis via the Nrf2 pathway in type 2 diabetes","volume":"202","author":"Li","year":"2024","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.jep.2026.121783_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115819","article-title":"Crataegus pinnatifida: a botanical, ethnopharmacological, phytochemical, and pharmacological overview","volume":"301","author":"Li","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2026.121783_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.810143","article-title":"Polyene phosphatidylcholine ameliorates high fat diet-induced non-alcoholic fatty liver disease via remodeling metabolism and inflammation","volume":"13","author":"Lu","year":"2022","journal-title":"Front. Physiol."},{"issue":"9","key":"10.1016\/j.jep.2026.121783_bib22","first-page":"1938","article-title":"[Guijianyu alleviates advanced glycation endproducts-induced mouse renal podocyte injury by inhibiting the AGEs-RAGE signaling pathway]","volume":"45","author":"Ma","year":"2025","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"1","key":"10.1016\/j.jep.2026.121783_bib23","article-title":"Effectiveness of phosphatidylcholine in alleviating steatosis in patients with non-alcoholic fatty liver disease and cardiometabolic comorbidities (MANPOWER study)","volume":"7","author":"Maev","year":"2020","journal-title":"BMJ Open Gastroenterol."},{"issue":"6","key":"10.1016\/j.jep.2026.121783_bib24","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1002\/ar.25333","article-title":"Soybean polyenylphosphatidylcholine (PPC) is beneficial in liver and extrahepatic tissue injury: an update in experimental research","volume":"307","author":"Mak","year":"2024","journal-title":"Anat. Rec."},{"issue":"2","key":"10.1016\/j.jep.2026.121783_bib25","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/joim.13531","article-title":"Current treatment of non-alcoholic fatty liver disease","volume":"292","author":"Paternostro","year":"2022","journal-title":"J. Intern. Med."},{"issue":"4","key":"10.1016\/j.jep.2026.121783_bib26","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2174\/1389450124666230113150116","article-title":"Therapeutic potential of herbal medicine against non-alcoholic fatty liver disease","volume":"24","author":"Pourali","year":"2023","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.jep.2026.121783_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116785","article-title":"Total saponins from Panax japonicus attenuate acute alcoholic liver oxidative stress and hepatosteatosis by p62-related Nrf2 pathway and AMPK-ACC\/PPAR\u03b1 axis in vivo and in vitro","volume":"317","author":"Qiu","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2026.121783_bib28","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1146\/annurev-med-042220-020407","article-title":"Fatty liver disease: diagnosis and stratification","volume":"73","author":"Saiman","year":"2022","journal-title":"Annu. Rev. Med."},{"issue":"3","key":"10.1016\/j.jep.2026.121783_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12030748","article-title":"Involvement of intracellular TAGE and the TAGE-RAGE-ROS axis in the onset and progression of NAFLD\/NASH","volume":"12","author":"Sakasai-Sakai","year":"2023","journal-title":"Antioxidants"},{"issue":"5","key":"10.1016\/j.jep.2026.121783_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052764","article-title":"Natural compounds for counteracting Nonalcoholic Fatty Liver Disease (NAFLD): advantages and limitations of the suggested candidates","volume":"23","author":"Salvoza","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.jep.2026.121783_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/nu12082393","article-title":"Metabolic impact of flavonoids consumption in obesity: from central to peripheral","volume":"12","author":"Sandoval","year":"2020","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.jep.2026.121783_bib32","doi-asserted-by":"crossref","first-page":"931","DOI":"10.4254\/wjh.v12.i11.931","article-title":"Inhibition of vascular adhesion protein-1 modifies hepatic steatosis in vitro and in vivo","volume":"12","author":"Shepherd","year":"2020","journal-title":"World J. Hepatol."},{"issue":"2","key":"10.1016\/j.jep.2026.121783_bib33","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.hepres.2005.11.004","article-title":"The efficacy of polyenylphosphatidylcholine for liver disease","volume":"34","author":"Shimizu","year":"2006","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.jep.2026.121783_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123473","article-title":"Polyenylphosphatidylcholine as bioactive excipient in tablets for the treatment of liver fibrosis","volume":"646","author":"Skorup","year":"2023","journal-title":"Int. J. Pharm."},{"issue":"12","key":"10.1016\/j.jep.2026.121783_bib35","doi-asserted-by":"crossref","first-page":"880","DOI":"10.4254\/wjh.v6.i12.880","article-title":"Involvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: novel treatment strategies","volume":"6","author":"Takeuchi","year":"2014","journal-title":"World J. Hepatol."},{"issue":"3","key":"10.1016\/j.jep.2026.121783_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12030541","article-title":"Hacking the lipidome: new ferroptosis strategies in cancer therapy","volume":"12","author":"Varynskyi","year":"2024","journal-title":"Biomedicines"},{"issue":"11","key":"10.1016\/j.jep.2026.121783_bib37","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1002\/ptr.8326","article-title":"Gardenia jasminoides ellis. Polysaccharides alleviated cholestatic liver injury by increasing the production of butyric acid and FXR activation","volume":"38","author":"Wang","year":"2024","journal-title":"Phytother Res."},{"issue":"3","key":"10.1016\/j.jep.2026.121783_bib38","first-page":"197","article-title":"Bupleuri radix extract ameliorates non-alcoholic fatty liver disease by suppressing AOC3-mediated PI3K\/AKT phosphorylation","volume":"35","author":"Wang","year":"2025","journal-title":"Journal of Jiangsu University (Medicine Edition)"},{"key":"10.1016\/j.jep.2026.121783_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.117841","article-title":"Chaihu Guizhi Ganjiang decoction attenuates nonalcoholic steatohepatitis by enhancing intestinal barrier integrity and ameliorating PPAR\u03b1 mediated lipotoxicity","volume":"326","author":"Wu","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2026.121783_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107571","article-title":"Ginsenoside Rg1: a bioactive therapeutic agent for diverse liver diseases","volume":"212","author":"Wu","year":"2025","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.jep.2026.121783_bib41","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jhep.2023.02.033","article-title":"Role of immune responses in the development of NAFLD-associated liver cancer and prospects for therapeutic modulation","volume":"79","author":"Yahoo","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jep.2026.121783_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155834","article-title":"Integrated bioinformatics and multiomics reveal Liupao tea extract alleviating NAFLD via regulating hepatic lipid metabolism and gut microbiota","volume":"132","author":"Yang","year":"2024","journal-title":"Phytomedicine"},{"issue":"3","key":"10.1016\/j.jep.2026.121783_bib43","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s12072-025-10782-x","article-title":"Global, regional, and national burden of liver cancer due to non-alcoholic steatohepatitis and non-alcoholic fatty liver disease, 1990-2021: a multi-model trend analysis and forecasting study","volume":"19","author":"Yang","year":"2025","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.jep.2026.121783_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107617","article-title":"AlphaFold-based AI docking reveals AMPK\/SIRT1-TFEB pathway modulation by traditional Chinese medicine in metabolic-associated fatty liver disease","volume":"212","author":"Zhang","year":"2025","journal-title":"Pharmacol. Res."},{"issue":"19","key":"10.1016\/j.jep.2026.121783_bib45","doi-asserted-by":"crossref","first-page":"9863","DOI":"10.1039\/D4FO01689K","article-title":"Effects of Mao tea from Nankun Mountain on nonalcoholic fatty liver disease in mice","volume":"15","author":"Zhang","year":"2024","journal-title":"Food Funct."},{"issue":"6","key":"10.1016\/j.jep.2026.121783_bib46","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1007\/s12640-021-00419-w","article-title":"Protective effect of Chitosan oligosaccharide against hydrogen peroxide-mediated oxidative damage and cell apoptosis via activating Nrf2\/ARE signaling pathway","volume":"39","author":"Zhang","year":"2021","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.jep.2026.121783_bib47","article-title":"Gut microbiota modulation by traditional Chinese medicine: a translational strategy for metabolic dysfunction-associated steatotic liver disease","volume":"16","author":"Zhou","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jep.2026.121783_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156458","article-title":"Polysaccharides from hawthorn fruit alleviate high-fat diet-induced NAFLD in mice by improving gut microbiota dysbiosis and hepatic metabolic disorder","volume":"139","author":"Zhou","year":"2025","journal-title":"Phytomedicine"}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874126006355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874126006355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:10:44Z","timestamp":1785755444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874126006355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":48,"alternative-id":["S0378874126006355"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2026.121783","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Qinggan Jiangzhi Cha ameliorates NAFLD by modulating the AGE-RAGE\/PRKCA\/MAPK3\/AP-1 signaling axis","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2026.121783","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"121783"}}